Indications and use
1. erectile dysfunction
The drug Talaris is indicated for the treatment of erectile dysfunction (ED).
Talaris is effective only in the presence of sexual stimulation.
2. Benign prostatic hyperplasia
Talaris is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH).
3 Erectile dysfunction and benign prostatic hyperplasia.
Talaris is indicated for the treatment of ED and signs and symptoms of BPH (ED/BPH).
How to use and dosage
The drug "Talaris" is taken by adults (men) orally, regardless of meals.
1. "Talaris" for use as needed for erectile dysfunction
The recommended starting dose of "Talaris" for use as needed in most patients is 10 mg taken before anticipated sexual activity.
The dose may be increased to 20 mg or decreased to 5 mg depending on individual efficacy and tolerability. The maximum recommended dosing frequency is once daily for most patients.
Talaris, as needed, has been shown to improve erectile function compared to placebo within 36 hours of dosing. Therefore, this should be considered when counseling patients on the optimal use of the drug.
2. "Talaris" for once daily use in erectile dysfunction
The recommended starting dose of "Talaris" for once daily use is 2.5 mg, taken at approximately the same time each day, regardless of the time of sexual activity.
The dose of Talaris for once-daily use may be increased to 5 mg depending on individual efficacy and tolerability.
3. "Talaris" for once daily use in benign prostatic hyperplasia
The recommended dose of Talaris for once daily use is 5 mg taken at approximately the same time each day.
When therapy for BPH is initiated with Tadalafil and finasteride, the recommended dose of Talaris for once daily use is 5 mg taken at approximately the same time each day for 26 weeks.
4. "Talaris" for once daily use for erectile dysfunction and benign prostatic hyperplasia
The recommended dose of "Talaris" for once daily use is 5 mg taken at approximately the same time each day, regardless of the time of sexual activity.